Roche navify digital solutions get excellent ratings from healthcare professionals in KLAS Research reports
* Healthcare professionals greatly value navify Tumor Board for improving tumour board meeting experiences, offering a holistic view of data, facilitating multidisciplinary team collaboration and optimising care decisions * navify POC Operations attains excellent ratings from health professio...
Economist Impact report, Advancing the frontier of health and technology integration: The 2023 Digital Health Barometer highlights opportunities in digitalisation of healthcare
* The report shows digital health technologies demonstrate value, yet integrating them into care systems remains challenging. Involving healthcare professionals and patients in technology design and development is also critical for patient-centred care.1 * The report surveyed 10 countries, al...
Roche introduces the navify brand for its digital health solutions at HLTH 2022
* Roche unifies its digital health portfolio under the navify brand, providing a range of next generation software solutions. * The navify portfolio uses digital solutions, analytics and data science to provide insights that address today's real-world challenges in health, enabling confident ...
NeuExcell Therapeutics and Spark Therapeutics Announce Research Collaboration Agreement to Develop a Novel Gene Therapy for Huntington's Disease
-- Using NeuExcell's neuroregenerative gene therapy platform, the collaboration aims to develop an effective and safe treatment for patients suffering from Huntington's Disease. -- Spark Therapeutics' excellence in R&D and proprietary adeno-associated virus (AAV) vector gene therapy platform ma...
Nimble Therapeutics Spins Out from Roche to Commercialize Novel Drug Discovery Technology with Financing from Telegraph Hill Partners
MADISON, Wisconsin, April 30, 2019 /PRNewswire/ -- Nimble Therapeutics has begun operating as a standalone business after spinning out from F. Hoffmann La Roche (SIX: RO, ROG; OTCQX: RHHBY) to commercialize its proprietary chemical synthesis technology for drug discovery and development. The comp...
Sigma-Aldrich Announces Exclusive Distribution Agreement with Roche
ST. LOUIS, March 19, 2015 /PRNewswire/ -- Sigma-Aldrich
